These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22830501)

  • 41. Personalized siRNA-Nanoparticle Systemic Therapy using Metastatic Lymph Node Specimens Obtained with EBUS-TBNA in Lung Cancer.
    Kato T; Lee D; Huang H; Cruz W; Ujiie H; Fujino K; Wada H; Patel P; Hu HP; Hirohashi K; Nakajima T; Sato M; Kaji M; Kaga K; Matsui Y; Chen J; Zheng G; Yasufuku K
    Mol Cancer Res; 2018 Jan; 16(1):47-57. PubMed ID: 28993508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
    Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue distribution and cancer growth inhibition of magnetic lipoplex-delivered type 1 insulin-like growth factor receptor shRNA in nude mice.
    Kong M; Li X; Wang C; Ding C; Dong A; Duan Q; Shen Z
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):591-6. PubMed ID: 22626974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.
    Gomes-da-Silva LC; Fernández Y; Abasolo I; Schwartz S; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
    Nanomedicine (Lond); 2013 Sep; 8(9):1397-413. PubMed ID: 23394132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.
    Huang Y; Lin D; Jiang Q; Zhang W; Guo S; Xiao P; Zheng S; Wang X; Chen H; Zhang HY; Deng L; Xing J; Du Q; Dong A; Liang Z
    Biomaterials; 2012 Jun; 33(18):4653-64. PubMed ID: 22480869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
    Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
    J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid-Based Liquid Crystalline Nanoparticles Facilitate Cytosolic Delivery of siRNA via Structural Transformation.
    He S; Fan W; Wu N; Zhu J; Miao Y; Miao X; Li F; Zhang X; Gan Y
    Nano Lett; 2018 Apr; 18(4):2411-2419. PubMed ID: 29561622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
    Lee E; Oh C; Kim IS; Kwon IC; Kim S
    J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.
    Shim G; Han SE; Yu YH; Lee S; Lee HY; Kim K; Kwon IC; Park TG; Kim YB; Choi YS; Kim CW; Oh YK
    J Control Release; 2011 Oct; 155(1):60-6. PubMed ID: 20971142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
    Choi YS; Lee JY; Suh JS; Kwon YM; Lee SJ; Chung JK; Lee DS; Yang VC; Chung CP; Park YJ
    Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial delivery of siRNAs: a new approach to solid tumor therapy.
    Xu DQ; Zhang L; Kopecko DJ; Gao L; Shao Y; Guo B; Zhao L
    Methods Mol Biol; 2009; 487():161-87. PubMed ID: 19301647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment.
    Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X
    Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.